Cannabinoids in Periodontology: Where Are We Now?-Reference-Cited by-同舟云学术

Cannabinoids in Periodontology: Where Are We Now?

Published:2023-11-30 Issue:12 Volume:12 Page:1687
ISSN:2079-6382
Container-title:Antibiotics
language:en
Short-container-title:Antibiotics

Author:

Carmona Rendón Yésica¹,Garzón Hernán Santiago²^ORCID,Bueno-Silva Bruno³^ORCID,Arce Roger M.⁴^ORCID,Suárez Lina Janeth¹⁵

Affiliation:

1. Departamento de Ciencias Básicas y Medicina Oral, Facultad de Odontología, Universidad Nacional de Colombia, Bogotá 111321, Colombia

2. Programa de Doctorado en Ingeniería, Facultad de Ingeniería, Pontificia Universidad Javeriana, Bogotá 110231, Colombia

3. Departamento de Biociências, Faculdade de Odontologia de Piracicaba, Universidade de Campinas (UNICAMP), Piracicaba 13414-903, Brazil

4. Department of Periodontics and Oral Hygiene, University of Texas School of Dentistry at Houston, Houston, TX 77054, USA

5. Centro de Investigaciones Odontológicas, Facultad de Odontología, Pontificia Universidad Javeriana, Bogotá 110231, Colombia

Abstract

Introduction: Cannabinoids are a well-documented treatment modality for various immune and inflammatory diseases, including asthma, chronic obstructive pulmonary disease, Crohn’s disease, arthritis, multiple sclerosis, and a range of neurodegenerative conditions. However, limited information is available regarding the therapeutic potential of cannabinoids in treating periodontal disease. Objective: The objective of this study is to analyze the current evidence on the antibacterial and immunomodulatory effects of cannabis and its role in the healing and regeneration processes within periodontal tissues. Results: This review discusses the potential role of cannabinoids in restoring periodontal tissue homeostasis. Conclusions: The examination of the endocannabinoid system and the physiological effects of cannabinoids in the periodontium suggests that they possess immunomodulatory and antibacterial properties, which could potentially promote proper tissue healing and regeneration.

Funder

Pontificia Universidad Javeriana, Bogotá, Colombia

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Link

https://www.mdpi.com/2079-6382/12/12/1687/pdf

Reference110 articles.

1. General and oral health implications of cannabis use;Cho;Aust. Dent. J.,2005

2. Clinical Use of Marijuana: The Thin Line Between Good and Evil?;Salazar;Arch. Med. Res.,2018

3. Medical cannabis: Aligning use to evidence-based medicine approach;Schleider;Br. J. Clin. Pharmacol.,2018

4. Medicinal use of cannabis based products and cannabinoids;Freeman;BMJ,2019

5. Bennici, A., Mannucci, C., Calapai, F., Cardia, L., Ammendolia, I., Gangemi, S., Calapai, G., and Soler, D.G. (2021). Safety of Medical Cannabis in Neuropathic Chronic Pain Management. Molecules, 26.